An edition of Anticancer drug development guide
(2004)
Anticancer drug development guide
preclinical screening, clinical trials, and approval
2nd ed.
by Beverly A. Teicher
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Previews available in: English
| Edition | Availability |
|---|---|
1
Anticancer drug development guide: preclinical screening, clinical trials, and approval
2004, Humana Press
in English
- 2nd ed.
1588292282 9781588292285
|
aaaa
|
2
Anticancer Drug Development Guide (Cancer Drug Discovery and Development)
February 2004, Humana Press
Hardcover
in English
- 1 edition
1588292282 9781588292285
|
zzzz
|
3
Anticancer drug development guide: preclinical screening, clinical trials, and approval
Publish date unknown, Humana Press
- 2nd ed.
1588292282 9781588292285
|
zzzz
|
Book Details
Table of Contents
High-volume screening / Michel Pagä
High-throughput screening in industry / Michael D. Boisclair ... [et al.]
The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd
Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff
Murine L1210 and P388 leukemias / William R. Waud
In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.]
Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.]
Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.]
Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman
Preclinical models for combination therapy / Beverly A. Teicher
Models for biomarkers and minimal residual tumor / Beverly A. Teicher
Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm
Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews
Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy
Nonclinical testing for oncology biologic products / Carolyn M. Laurenìot, Denis Roy, and Paul A. Andrews
Working with the national cancer institute / Paul Thambi and Edward A. Sausville
Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin
Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer
Drug development in Europe: the academic perspective / Chris Twelves ... [et al.]
The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur
Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel
The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari
FDA role in cancer drug development and requirements for approval / Susan Flamm Honig.
Edition Notes
Includes bibliographical references and index.
Minimum system requirements: Adobe reader 6.0 or later.
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
| October 4, 2021 | Edited by ImportBot | import existing book |
| June 28, 2019 | Edited by MARC Bot | import existing book |
| February 18, 2019 | Created by MARC Bot | import existing book |